Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.78
- Piotroski Score 7.00
- Grade Outperform
- Symbol (ZBH)
- Company Zimmer Biomet Holdings, Inc.
- Price $104.72
- Changes Percentage (0.44%)
- Change $0.46
- Day Low $103.69
- Day High $104.76
- Year High $133.90
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
- Last Earnings 08/29/2024
- Ex-Dividend for 5/16 Dividend 09/30/2024
- Dividend Payable 10/31/2024
- Today N/A
- Next Earnings (Estimated) 10/30/2024
- Fiscal Year End N/A
- Average Stock Price Target $130.00
- High Stock Price Target $180.00
- Low Stock Price Target $110.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $4.61
- Trailing P/E Ratio 24.59
- Forward P/E Ratio 24.59
- P/E Growth 24.59
- Net Income $1.02 B
Income Statement
Quarterly
Annual
Latest News of ZBH
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Is It Time To Consider Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Zimmer Biomet Holdings' stock price fluctuated between highs of US$116 and lows of US$102. Currently trading at US$104, it seems undervalued with potential for growth. The company's low P/E ratio and ...
By Yahoo! Finance | 1 week ago -
Zimmer Biomet Holdings, Inc. (ZBH) Stock Forecasts
ESG investing focuses on Environmental, Social, and Governance factors in companies. It has gained popularity among investors, leading to a rise in ESG ETFs. Despite its strengths, challenges like 'gr...
By Yahoo! Finance | 2 months ago -
The Strong Earnings Posted By Zimmer Biomet Holdings (NYSE:ZBH) Are A Good Indication Of The Strength Of The Business
Zimmer Biomet Holdings, Inc.'s recent earnings were solid, despite being overlooked by the market. Unusual expenses impacted profits, but future profitability is expected to improve. Earnings per shar...
By Yahoo! Finance | 2 months ago
